Enhanced Production of Nargenicin A1 and Generation of Novel Glycosylated Derivatives

Applied Biochemistry and Biotechnology

Volumn 175, Issue 6, 2015, Pages 2934-2949

  Dhakal, Dipesh ^a   Le, Tuoi Thi ^a   Pandey, Ramesh Prasad ^a   Jha, Amit Kumar ^a   Gurung, RitBahadur ^a   Parajuli, Prakash ^a   Pokhrel, Anaya Raj ^a   Yoo, Jin Cheol ^b   Sohng, Jae Kyung ^a  

^a SunMoon University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Glucopyranoside; Nargenicin A1; Nocardia sp. CS682; Novel nargenicin A1; One pot glycosylation

Indexed keywords

BACTERIOLOGY; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; GLUCOSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KETONES; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLUBILITY;

GLUCOPYRANOSIDE; NARGENICIN A1; NOCARDIA SP. CS682; NOVEL NARGENICIN A1; ONE POT;

NUCLEAR MAGNETIC RESONANCE;

AMPICILLIN; GLYCOSIDE; GLYCOSYLTRANSFERASE; MACROLIDE; NARGENICIN A1; NARGENICIN A1 11 O BETA DEXTRO GLUCOPYRANOSIDE; NARGENICIN A1 18 O BETA DEXTRO DEOXYGLUCOPYRANOSIDE; NARGENICIN A1 18 O BETA DEXTRO DIGLUCOPYRANOSIDE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; ANTIINFECTIVE AGENT; GLUCOSE; LACTONE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS LICHENIFORMIS; BACILLUS SUBTILIS; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ENTEROBACTER CLOACAE; GLYCOSYLATION; MICROCOCCUS LUTEUS; NOCARDIA; NONHUMAN; ONE POT SYNTHESIS; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLIC ENGINEERING; METABOLISM;

BACILLUS LICHENIFORMIS; NOCARDIA SP.;

ANTI-BACTERIAL AGENTS; GLUCOSE; GLYCOSYLATION; LACTONES; METABOLIC ENGINEERING; MOLECULAR STRUCTURE; NOCARDIA;

EID: 84924040451     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-014-1472-3     Document Type: Article

References (43)

1. Celmer, W. D., Chmurny, G. N., Moppett, C. E., Ware, R. S., Watts, P. C., & Whipple, E. B. (1980). Structure of natural antibiotic CP-47,444. Journal of the American Chemical Society, 102, 4203–4209.
2. Sohng, J. K., Yamaguchi, T., Seong, C. N., Baik, K. S., Park, S. C., Lee, H., Jang, J., Simkhada, J., & Yoo, J. C. (2008). Production, isolation and biological activity of nargenicin from Nocardia sp. CS682. Archives of Pharmacal Research, 31, 1339–1345.
3. Kim, S. H., Yoo, J. C., & Kim, T. S. (2009). Nargenicin enhances 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced leukemia cell differentiation via PKCβI/MAPK pathways. Biochemical Pharmacology, 77, 1694–1701.
4. Yoo, J. C., Cho, H. S., Park, E., Park, J. A., Kim, S., Kim, D. K., Kim, C. S., & Chun, H. S. (2009). Nargenicin attenuates lipopolysaccharide-induced inflammatory responses in BV-2 cells. Neuroreport, 20, 1007–1012.
5. Zhanel, G. G., Dueck, M., Hoban, D. J., Vercaigne, L. M., Embil, J. M., Gin, A. S., & Karlowsky, J. A. (2001). Review of macrolides and ketolides. Drugs, 61, 443–498.
6. Painter, R. E., Goetz, M., Gill, C., Allocco, J., Nare, B., Powles, M., & Young, K. (2011), Presentation abstract, Merck Res. Lab., Rahway, USA.
7. Olano, C., Lombó, F., Méndez, C., & Salas, J. A. (2008). Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering. Metabolic Engineering, 10, 281–292.
8. Olano, C., Méndez, C., & Salas, J. A. (2011). Molecular insights on the biosynthesis of antitumour compounds by actinomycetes. Microbial Biotechnology, 4, 144–164.
9. Periti, P., Mazzei, T., Mini, E., & Novelli, A. (1989). Clinical pharmacokinetic properties of the macrolide antibiotics. Clinical Pharmacokinetics, 16, 193–214.
10. Gorska, M., Popowska, U., Sielicka-Dudzin, A., Kuban-Jankowska, A., Sawczuk, W., Knap, N., Cicero, G., & Wozniak, F. (2011). Geldanamycin and its derivatives as Hsp90 inhibitors. Frontiers in Bioscience (Landmark edition), 17, 2269–2277.
11. Simkhada, D., Lee, H. C., & Sohng, J. K. (2010). Genetic engineering approach for the production of rhamnosyl and allosyl flavonoids from Escherichia coli. Biotechnology and Bioengineering, 107, 154–162.
12. Singh, S., Phillips, G. N., Jr., & Thorson, J. S. (2012). The structural biology of enzymes involved in natural product glycosylation. Natural Product Reports, 29, 1201–1237.
13. Kren, V., & Martínková, L. (2001). Glycosides in medicine: “the role of glycosidic residue in biological activity”. Current Medicinal Chemistry, 8, 1303–1328.
14. Weymouth-Wilson, A. C. (1997). The role of carbohydrates in biologically active natural products. Natural Product Reports, 14, 99–110.
15. Pandey, R. P., Parajuli, P., Koirala, N., Park, J. W., & Sohng, J. K. (2013). Probing 3-hydroxyflavone for in vitro glycorandomization of flavonols by YjiC. Applied and Environmental Microbiology, 79, 6833–6838.
16. Desmet, T., Soetaert, W., Bojarová, P., Křen, V., Dijkhuizen, L., Eastwick-Field, V., & Schiller, A. (2012). Enzymatic glycosylation of small molecules: challenging substrates require tailored catalysts. Chemistry--A European Journal, 18, 10786–10801.
17. Malla, S., Pandey, R. P., Kim, B. G., & Sohng, J. K. (2013). Regiospecific modifications of naringenin for astragalin production in Escherichia coli. Biotechnology and Bioengineering, 110, 2525–2535.
18. Lee, H. C., Lee, S. D., Sohng, J. K., & Liou, K. (2004). One-pot enzymatic synthesis of UDP-D-glucose from UMP and glucose-1-phosphate using an ATP regeneration system. Journal of Biochemistry and Molecular Biology, 37, 503–506.
19. Yang, Y. H., Kang, Y. B., Kim, D. H., Lee, T. H., Park, S. H., Lee, K., Yoo, D., Liou, K. K., Lee, H. C., Sohng, J. K., & Kim, B. G. (2010). One-pot enzymatic synthesis of deoxy-thymidine-diphosphate (TDP)-2-deoxy-α-D-glucose using phosphomannomutase. Journal of Molecular Catalysis B: Enzymatic, 62, 282–287.
20. Masada, S., Kawase, Y., Nagatoshi, M., Oguchi, Y., Terasaka, K., & Mizukami, H. (2007). An efficient chemoenzymatic production of small molecule glucosides with in situ UDP-glucose recycling. FEBS Letters, 581, 2562–2566.
21. Terasaka, K., Mizutani, Y., Nagatsu, A., & Mizukami, H. (2012). In situ UDP-glucose regeneration unravels diverse functions of plant secondary product glycosyltransferases. FEBS Letters, 586, 4344–4350.
22. Tuoi, L. T., Pandey, R. P., Gurung, R. B., Dhakal, D., & Sohng, J. K. (2014). Efficient enzymatic systems for synthesis of novel α-mangostin glycosides exhibiting antibacterial activity against Gram-positive bacteria. Applied Microbiology and Biotechnology, 98, 8527–8538.
23. Koju, D., Dhakal, D., & Sohng, J. K. (2012). Effect of different biosynthetic precursors on the production of nargenicin A1 from metabolically engineered Nocardia sp. CS682. Journal of Microbiology and Biotechnology, 22, 1127–1132.
24. Walsh, C. T., Garneau-Tsodikova, S., & Howard-Jones, A. R. (2006). Biological formation of pyrroles: nature's logic and enzymatic machinery. Natural Product Reports, 23, 517–531.
25. Maharjan, S., Aryal, N., Bhattarai, S., Koju, D., Lamichhane, J., & Sohng, J. K. (2012). Biosynthesis of the nargenicin A1 pyrrole moiety from Nocardia sp. CS682. Applied Microbiology and Biotechnology, 93, 687–696.
26. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248–254.
27. Chaudhary, A. K., Dhakal, D., &Sohng, J. K. (2013). An insight into the “-omics” based engineering of streptomycetes for secondary metabolite overproduction. BioMedResearch International, 2013, 968518.
28. Lee, S. Y., Kim, H. U., Park, J. H., Park, J. M., & Kim, T. Y. (2009). Metabolic engineering of microorganisms: general strategies and drug production. Drug Discovery Today, 14, 78–88.
29. Maharjan, S., Koju, D., Lee, H. C., Yoo, J. C., & Sohng, J. K. (2012). Metabolic engineering of Nocardia sp. CS682 for enhanced production of nargenicin A1. Applied Biochemistry and Biotechnology, 166, 805–817.
30. Gao, Y., Fan, Y., Nambou, K., Wei, L., Liu, Z., Imanaka, T., & Hua, Q. (2014). Enhancement of ansamitocin P-3 production in Actinosynnemapretiosum by a synergistic effect of glycerol and glucose. Journal of Industrial Microbiology & Biotechnology, 41, 143–152.
31. Paudel, S., Lee, H. C., Kim, B. S., & Sohng, J. K. (2011). Enhancement of pradimicin production in Actinomadurahibisca P157-2 by metabolic engineering. Microbiological Research, 167, 32–39.
32. Maharjan, S., Oh, T. J., Lee, H. C., & Sohng, J. K. (2008). Heterologous expression of metK1-sp and afsR-sp in Streptomyces venezuelae for the production of pikromycin. Biotechnology Letters, 30, 1621–1626.
33. Jha, A. K., Lamichhane, J., & Sohng, J. K. (2014). Enhancement of herboxidiene production in Streptomyces chromofuscus ATCC 49982. Journal of Microbiology and Biotechnology, 24, 52–58.
34. White-Phillip, J., Thibodeaux, C. J., & Liu, H. W. (2009). Enzymatic synthesis of TDP-deoxysugars. Methods in Enzymology, 459, 521–544.
35. Gantt, R. W., Peltier-Pain, P., & Thorson, J. S. (2011). Enzymatic methods for glyco (diversification/randomization) of drugs and small molecules. Natural Product Reports, 28, 1811–1853.
36. Furumoto, T., Yoshika, T., Kamata, K., Kameda, Y., & MatsuiI, K. (1991). Enzymic synthesis of valienamine glucosides and their antibiotic activity. Journal of Antibiotics, 44, 371–373.
37. Glycosylated aminocoumarins and methods of preparing and uses of same. Available from http://www.google.com/patents/EP2627661A1?cl=en. Accessed 30 Jul 2014
38. Williamson, G., Plumb, G. W., Uda, Y., Price, K. R., & Rhodes, M. J. (1996). Dietary quercetin glycosides: antioxidant activity and induction of the anticarcinogenic phase II marker enzyme quinone reductase in Hepalclc7 cells. Carcinogenesis, 17, 2385–2387.
39. Priyadarsini, K. I., Maity, D. K., Naik, G. H., Kumar, M. S., Unnikrishnan, M. K., Satav, J. G., & Mohan, H. (2003). Role of phenolic OH and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radical Biology and Medicine, 35, 475–484.
40. Pandey, R. P., Gurung, R. B., Parajuli, P., Koirala, N., Tuoi, L. T., & Sohng, J. K. (2014). Assessing acceptor substrate promiscuity of YjiC-mediated glycosylation toward flavonoids. Carbohydrate Research, 393, 26–31.
41. Gurung, R. B., Kim, E. H., Oh, T. J., & Sohng, J. K. (2013). Enzymatic synthesis of apigenin glucosides by glucosyltransferase (YjiC) from Bacillus licheniformis DSM 13. Molecules and Cells, 36, 355–361.
42. Wu, C. Z., Jang, J. H., Woo, M., Ahn, J. S., Kim, J. S., & Hong, Y. S. (2012). Enzymatic glycosylation of nonbenzoquinone geldanamycin analogs via Bacillus UDP-glycosyltransferase. Applied and Environmental Microbiology, 78, 7680–7686.
43. Parajuli, P., Pandey, R. P., Koirala, N., Yoon, Y. J., Kim, B. G., & Sohng, J. K. (2014). Enzymatic synthesis of epothilone A glycosides. AMB Express, 4, 31.